FDA
approval
· 2026-02-23
FDA Approved: IPRATROPIUM BROMIDE INHALATION — Original Application (Armstrong Pharmaceuticals, Inc.)
Summary
FDA approved Armstrong Pharmaceuticals' ipratropium bromide inhalation under an original ANDA. It is approved for relief of bronchospasm associated with chronic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for IPRATROPIUM BROMIDE INHALATION (IPRATROPIUM BROMIDE INHALATION)